维普期刊资源整合服务平台（V6.5）

86篇 您的检索式：作者名="Zucali"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Results of irradiation in the treatment of chest wall recurrent breast cancer 显示文摘	KENDA R LOZZA L ZUCALI R	1992	Radiother Oncol1992，24，1：	1
2	Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy? 显示文摘	Masci G Magagnoli M Zucali PA	2003	J Clin Oneol2003，21，4：	1
3	Src as a potential therapeutic tar-get in non-small-cell lung cancer显示文摘	Giaccone G Zucali PA	2008	Ann Oncol2008，19，7：	1
4	Aldehyde dehydrogenase ac- tivity as a functional marker for lung cancer显示文摘	Ucar D Cogle CR Zucali JR	2009	Chem Biol Inter- act2009，178，1：	1
5	Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?显示文摘	Masci G Magagnoli M Zucali PA	2003	J Clin Oncol2003，21，4：	1
6	Src as a potential therapeutic tar- get in non-small-cell lung cancer显示文摘	Giaccone G Zucali PA	2008	Ann 0ncol2008，19，7：	1
7	Phase II study ofpemetrexed plus carboplatin in malignant pleural mesothelioma显示文摘	Ceresoli GL Zucali PA Favaretto AG	2006	J Clin Oncol2006，24，9：	1
8	Retreatment with pemetrexed based chemotherapy in patients with malignant pleural mesothelioma显示文摘	Ceresoli G Zucali PA De Vincenzo F	2011	Lung Cancer2011，72，1：	1
9	Impact of ABCG2 polymorphisms on the clinical outcome and tox- icity of gefitinib in non-small-cell lung cancer patients显示文摘	Lemos C Giovannetti E Zucali PA	2011	Pharmacogenomics2011，12，2：	1
10	Thymidy- late synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin 显示文摘	Zucali P A Giovannetti E Destro A	2011	Clini- cal Cancer Research2011，17，8：	1
11	Pemetrexed plus carbo-platin in elderly patients with malignant pleural mesothelioma: com-bined analysis of two phase II trials显示文摘	Ceresoli GL Castagneto B Zucali PA*	2008	Br J Cancer2008，99，1：	1
12	Aldehyde dehydrogenase activity as a functional marker for lung cancer 显示文摘	Ucar D Cogle CR Zucali JR	2009	Chem Biol Interact2009，178，13：	1
13	Neoadjuvamt chemothera- py colloque显示文摘	Valagussa P Zambetti M Zucali R	1998	Inserm1998，169，：	1
14	Primary chemotherapy in surgically respectable breast cancer显示文摘	Bonadonna G Valagussa P Zucali R	1995	CA Cancer J Clin1995，45，4：	1
15	Conservative treatment of breast cancerwith QUART technique显示文摘	Veronesi U Zucali R Vecchio MD	1985	World J surg1985，9，5：	1
16	Phase Ⅱ study of asparagine-glycine-arginine-human tumor necrosis factor alpha,a selective vascular targeting agent,in previously treated patients with malignant pleural mesothelioma显示文摘	Gregorc V Zucali PA Santoro A		0，，15：	1
17	Phase II study of as- paragine-glycine-arginine-human tumor necrosis factor a, a selec-tive vascular targeting agent, in previously treated patients with malignant pleural mesothelioma 显示文摘	Vanesa G Zucali PA Armando S	2010	J Clin Oncol2010，28，15：	1
18	Primary chemotherapy in surgically resectable breast cancer显示文摘	Bonadonna G Valagussa P Zucali R	1995	CA Cancer J Clin1995，45，：	1
19	Future developments in the management of malignant pleural mesothelioma显示文摘	Zucali PA De Vincenzo F Simonelli M		0，，：	1
20	Association of poly- morphisms in AKT1 and EGFR with clinical outcome and toxicity in non-small cell lung cancer patients treated with gefitinib显示文摘	Giovannetti E Zucali PA Peters GJ	2010	Mol Cancer Ther2010，9，3：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示